ticlopidine has been researched along with Colorectal Cancer in 3 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin use after diagnosis of colorectal cancer was associated with significantly lower mortality rates and this effect remained significant after adjusting for potential confounders." | 7.85 | The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer. ( Bastiaannet, E; Frouws, MA; Lemmens, VE; Liefers, GJ; Portielje, JEA; Rademaker, E; Van de Velde, CJH; van Herk-Sukel, MPP, 2017) |
| "Aspirin use after diagnosis of colorectal cancer was associated with significantly lower mortality rates and this effect remained significant after adjusting for potential confounders." | 3.85 | The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer. ( Bastiaannet, E; Frouws, MA; Lemmens, VE; Liefers, GJ; Portielje, JEA; Rademaker, E; Van de Velde, CJH; van Herk-Sukel, MPP, 2017) |
| "Colorectal, breast and prostate cancer patients, newly diagnosed from 1998 to 2009, were identified from the National Cancer Data Repository." | 1.42 | Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients. ( Cardwell, CR; Hicks, BM; Hughes, C; Murray, LJ, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frouws, MA | 1 |
| Rademaker, E | 1 |
| Bastiaannet, E | 1 |
| van Herk-Sukel, MPP | 1 |
| Lemmens, VE | 1 |
| Van de Velde, CJH | 1 |
| Portielje, JEA | 1 |
| Liefers, GJ | 1 |
| Lin, D | 1 |
| Soetikno, RM | 1 |
| McQuaid, K | 1 |
| Pham, C | 1 |
| Doan, G | 1 |
| Mou, S | 1 |
| Shergill, AK | 1 |
| Somsouk, M | 1 |
| Rouse, RV | 1 |
| Kaltenbach, T | 1 |
| Hicks, BM | 1 |
| Murray, LJ | 1 |
| Hughes, C | 1 |
| Cardwell, CR | 1 |
3 other studies available for ticlopidine and Colorectal Cancer
| Article | Year |
|---|---|
The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Colorectal Neoplasms; Dipyridamole; Drug Thera | 2017 |
Risk factors for postpolypectomy bleeding in patients receiving anticoagulation or antiplatelet medications.
Topics: Aged; Anticoagulants; Aspirin; Case-Control Studies; Clopidogrel; Colonic Polyps; Colonoscopy; Color | 2018 |
Clopidogrel use and cancer-specific mortality: a population-based cohort study of colorectal, breast and prostate cancer patients.
Topics: Aged; Aged, 80 and over; Breast Neoplasms; Cause of Death; Clopidogrel; Colorectal Neoplasms; Databa | 2015 |